Entry |
|
Name |
Nefazodone (INN) |
Formula |
C25H32ClN5O2
|
Exact mass |
469.2245
|
Mol weight |
470.0069
|
Structure |
|
Simcomp |
|
Remark |
Product (DG00953): | D00819<US> |
|
Efficacy |
Antidepressant |
Comment |
Phenylpiperazine derivative
|
Target |
|
Pathway |
hsa04080 | Neuroactive ligand-receptor interaction |
|
Interaction |
|
Structure map |
|
Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
N NERVOUS SYSTEM
N06 PSYCHOANALEPTICS
N06A ANTIDEPRESSANTS
N06AX Other antidepressants
N06AX06 Nefazodone
D08257 Nefazodone (INN)
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Adrenaline
ADRA1
D08257 Nefazodone (INN)
Serotonin
HTR2A
D08257 Nefazodone (INN)
HTR2C
D08257 Nefazodone (INN)
|
Other DBs |
|
LinkDB |
|
KCF data |
ATOM 33
1 N4y N 23.5470 -20.1204
2 C8y C 23.8963 -18.7232
3 C8y C 24.6647 -20.8888
4 C1b C 22.2895 -20.8190
5 N5x N 25.3633 -18.7230
6 C1b C 23.0580 -17.6054
7 N4y N 25.7825 -20.0505
8 O5x O 24.6646 -22.2860
9 C1b C 21.1019 -20.1204
10 C1a C 23.6168 -16.3479
11 C1b C 26.9002 -20.7491
12 O2a O 19.8444 -20.8190
13 C1b C 28.0180 -20.0505
14 C8y C 18.6568 -20.1204
15 C1b C 29.2056 -20.7491
16 C8x C 17.3994 -20.8190
17 C8x C 18.6568 -18.6533
18 N1y N 30.3233 -20.0505
19 C8x C 16.2117 -20.1204
20 C8x C 17.3994 -17.9547
21 C1x C 30.3233 -18.5835
22 C1x C 31.5110 -20.7491
23 C8x C 16.2117 -18.6533
24 C1x C 31.5110 -17.8849
25 C1x C 32.6986 -20.0505
26 N1y N 32.6986 -18.5835
27 C8y C 33.9560 -17.8849
28 C8x C 33.9560 -16.4877
29 C8x C 35.1436 -18.5835
30 C8y C 35.1436 -15.7891
31 C8x C 36.4011 -17.8849
32 C8x C 36.4011 -16.4877
33 X Cl 35.1436 -14.3919
BOND 36
1 1 2 1
2 1 3 1
3 1 4 1
4 2 5 2
5 2 6 1
6 3 7 1
7 3 8 2
8 4 9 1
9 6 10 1
10 7 11 1
11 9 12 1
12 11 13 1
13 12 14 1
14 13 15 1
15 14 16 2
16 14 17 1
17 15 18 1
18 16 19 1
19 17 20 2
20 18 21 1
21 18 22 1
22 19 23 2
23 21 24 1
24 22 25 1
25 24 26 1
26 26 27 1
27 27 28 2
28 27 29 1
29 28 30 1
30 29 31 2
31 30 32 2
32 30 33 1
33 5 7 1
34 20 23 1
35 25 26 1
36 31 32 1
|